MICHELLE DAVIS: Open Payments
NPI 1881951994 · ATHENS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,361 in 191 payments from 35 companies in 2025. Trend: 2023 $2,718 · 2024 $4,499 · 2025 $3,361
Food & beverage: $3,361
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 48 | $729 |
| PFIZER INC. | 18 | $229 |
| Otsuka America Pharmaceutical, Inc. | 17 | $203 |
| AstraZeneca Pharmaceuticals LP | 7 | $194 |
| Medtronic, Inc. | 4 | $148 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $147 |
| Axsome Therapeutics, Inc. | 7 | $122 |
| Lundbeck LLC | 5 | $116 |
| Madrigal Pharmaceuticals | 6 | $109 |
| Novartis Pharmaceuticals Corporation | 5 | $100 |
Products named: REXULTI, VRAYLAR, AIRSUPRA, RINVOQ, MINIMED 780G, ENTYVIO, Auvelity, NURTEC ODT.
Industry payments across TN — which companies pay providers there.
